Purpose of this retrospective study was (1) to evaluate overall survival and survival to local recurrence of patients with unifocal and multifocal tumor and (2) to evaluate survival to local recurrence after intralesional or wide surgery.We reviewed 62 patients with epithelioid hemangioendothelioma of bone, treated from 1985 to 2010. Histological sections and immunohistochemistry were evaluated. Tumor presented as unifocal in 49 patients and as multifocal in 13.Mean follow\u2010up was 9 years. Five patients (10%) with unifocal tumor progressed to multifocal. Overall survival was 92% at 10 years. Survival with unifocal tumor was significantly higher than survival with multifocal tumor. Survival to local recurrence was 76% at 10 years, signif...
Background: This review of the literature combined with a clinical case will allow the illustration ...
BackgroundEpithelioid hemangioendothelioma (EHE) is an extremely uncommon malignant neoplasm that or...
Background: This multicentric, retrospective study conducted within the Italian Rare Cancer Network ...
OBJECTIVE: Purpose of this retrospective study was (1) to evaluate overall survival and survival to ...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Epithelioid hemangioendothelioma is a rare vascular tumor, described for the first time in 1975 by ...
Background: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with malignant biologica...
BACKGROUND/AIM: Epithelioid haemangioendothelioma (EHE) is a rare tumor with a wide spectrum of clin...
Abstract Background Epithelioid hemangioendothelioma is an exceedingly rare sarcoma often occurring ...
Abstract Background Epithelioid hemangioendothelioma (EHE) is a rare malignant vascular neoplasm wit...
Review on Bone: Epithelioid hemangioendothelioma, with data on clinics, and the genes involved
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
PURPOSE: The aim of this study was to assess treatment and outcome with respect to clinical and pat...
A multicentric epithelioid hemangioendothelioma (EHE) of the bone is reported which affected the rig...
INTRODUCTION: Hemangioendotheliomas are locally aggressive vascular tumors with intermediate maligni...
Background: This review of the literature combined with a clinical case will allow the illustration ...
BackgroundEpithelioid hemangioendothelioma (EHE) is an extremely uncommon malignant neoplasm that or...
Background: This multicentric, retrospective study conducted within the Italian Rare Cancer Network ...
OBJECTIVE: Purpose of this retrospective study was (1) to evaluate overall survival and survival to ...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Epithelioid hemangioendothelioma is a rare vascular tumor, described for the first time in 1975 by ...
Background: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with malignant biologica...
BACKGROUND/AIM: Epithelioid haemangioendothelioma (EHE) is a rare tumor with a wide spectrum of clin...
Abstract Background Epithelioid hemangioendothelioma is an exceedingly rare sarcoma often occurring ...
Abstract Background Epithelioid hemangioendothelioma (EHE) is a rare malignant vascular neoplasm wit...
Review on Bone: Epithelioid hemangioendothelioma, with data on clinics, and the genes involved
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
PURPOSE: The aim of this study was to assess treatment and outcome with respect to clinical and pat...
A multicentric epithelioid hemangioendothelioma (EHE) of the bone is reported which affected the rig...
INTRODUCTION: Hemangioendotheliomas are locally aggressive vascular tumors with intermediate maligni...
Background: This review of the literature combined with a clinical case will allow the illustration ...
BackgroundEpithelioid hemangioendothelioma (EHE) is an extremely uncommon malignant neoplasm that or...
Background: This multicentric, retrospective study conducted within the Italian Rare Cancer Network ...